Serum Sickness-Like Reactions After Pneumococcal Vaccination

Chung, Bing-Syuan; Liu, Wei-Ting; Chen, Po‐Wei

doi:10.7759/cureus.17877

Cited by 2 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They are most associated with ß-lactam antibiotics (especially cefaclor and amoxicillin), sulfonamides, fluoroquinolones, aromatic anticonvulsants, tetracyclines, minocycline, metronidazole, bupropion, and other drugs including biologicals ( Lawley et al, 1984 ; Platt et al, 1988 ; Heckbert et al, 1990 ; Weiss and Smith, 2020 ). This type of reactions can also develop as a result of vaccine administration including recent cases of SSLR to inactivated COVID-19 vaccine ( Chung et al, 2021 ; Chaijaras et al, 2022 ). The condition is defined by sudden appearance of skin rash (usually urticaria-like) and arthritis usually manifested 1–3 weeks after drug exposure, which can be accompanied by fever, lymphadenopathy, eosinophilia, and rarely renal involvement ( Del Pozzo-Magana et al, 2021 ).…”

Section: Introductionmentioning

confidence: 99%

The role of in vitro testing in pharmacovigilance for ß-lactam-induced serum sickness-like reaction: A pilot study

et al. 2022

View full text Add to dashboard Cite

Background: Current pharmacovigilance (PV) methods for detection of adverse drug reactions (ADRs) fail to capture rare immune-mediated drug hypersensitivity reactions (DHRs) due to their scarcity and the lack of clear diagnostic criteria. Drug-induced serum sickness-like reactions (SSLRs) are rare type of DHRs that occur in susceptible patients 1–3 weeks after exposure to the culprit drug with ß-lactam antibiotics being the most associated drugs. The diagnosis of drug induced SSLR is difficult due to the lack of safe and reliable diagnostic tests for identifying the culprit drug. The lymphocyte toxicity assay (LTA) is an in vitro test used as a diagnostic tool for drug hypersensitivity reactions (DHRs).Objective: To evaluate the role of the LTA test for diagnosing and capturing SSLR due to ß-lactam antibiotics in a cohort of patients.Methods: Patients were recruited from patients referred to the Drug Hypersensitivity Clinic at Clinic at London Health Science Centre with suspicion of drug allergy. Twenty patients (10 males and 10 females) were selected to be tested to confirm diagnosis. Demographic data was collected form the patents and blood samples were withdrawn from all patients and from 20 healthy controls. The LTA test was performed on all subjects and data is expressed as percentage increase in cell death compared to control (vehicle without the drug).Results: In the result of LTA tests performed on samples from the selected 20 patients. There was a significant (p < 0.05) concentration-dependent increase in cell death in cells isolated from patients as compared to cells from healthy controls when incubated with the drug in the presence of phenobarbitone-induced rat liver microsomes.Conclusion: Giving its safety and good predictive value the LTA test has very strong potential to be a useful diagnostic tool for ß-lactam-induced SSLR. The test procedure is relatively simple and not overly costly. Further studies including other drug classes are needed to evaluate the utility of the LTA test for SSLR due to other drugs.

show abstract

Section: Introductionmentioning

confidence: 99%

The role of in vitro testing in pharmacovigilance for ß-lactam-induced serum sickness-like reaction: A pilot study

et al. 2022

View full text Add to dashboard Cite

show abstract

Reacciones de hipersensiblidad tardía a medicamentos: Reporte de Grupo del Comité de Alergia a Medicamentos del Colegio Mexicano de Inmunología Clínica y Alergia (CMICA)

Villarreal-González,

Ortega-Cisneros,

Cadenas-García

et al. 2024

Rev Alerg Mex

View full text Add to dashboard Cite

Background: Adverse drug reactions are defined as unexpected reactions, either derived from the pharmacokinetics of the treatment (Type A) or as a host immune response (Type B), resulting in harmful or undesirable manifestations in the patient following the administration of pharmacological therapy. Type B reactions are less defined and are considered a result of hypersensitivity to pharmacological treatment, categorized as immediate (within 1 to 6 hours after exposure) and delayed or non-immediate (occurring 6 hours after exposure). Objective: A review to describe the immunological mechanisms of delayed hypersensitivity reactions to drugs. Methods: A search of major medical databases on delayed hypersensitivity reactions to drugs was conducted. The review was limited to articles published in the period between 2013 and 2023, taking into consideration articles written in English and Spanish. Results: The terms defining delayed hypersensitivity reactions to drugs, their classification, clinical manifestations, diagnosis, treatment algorithms, and prognosis. Conclusion: Adverse drug reactions represent a challenge for the specialist physician, with a complex pathophysiology. A prompt diagnosis and treatment focused on the drug phenotype and its immunological expression are required to provide a multidisciplinary approach. Keywords: Drug allergy; Hypersensitivity reactions to drugs; Adverse reactions to drugs; Delayed drug reactions.

show abstract

Serum Sickness-Like Reactions After Pneumococcal Vaccination

Cited by 2 publications

References 14 publications

The role of in vitro testing in pharmacovigilance for ß-lactam-induced serum sickness-like reaction: A pilot study

The role of in vitro testing in pharmacovigilance for ß-lactam-induced serum sickness-like reaction: A pilot study

Reacciones de hipersensiblidad tardía a medicamentos: Reporte de Grupo del Comité de Alergia a Medicamentos del Colegio Mexicano de Inmunología Clínica y Alergia (CMICA)

Contact Info

Product

Resources

About